Acute lymphoblastic leukemia (ALL) is a malignant neoplasm of the lymphocyte precursor cells. Among adults it is a relatively rare neoplasm with a curability rate around 30% at 5 years. Currently, the diagnosis and classification of ALL is a multistep procedure that relies on the simultaneous application of multiple techniques that include: cytomorphology, immunophenotype and cytogenetic assays. Some of them have important clinical implications for both diagnosis and predicting response to specific treatment regimens, while the role of others is still to be defined. Over the years, several prognostic factors have been identified and today a risk stratification at diagnosis and during the follow-up is based on the characteristics of the leukemic cells.

Download full-text PDF

Source
http://dx.doi.org/10.1515/rjim-2015-0004DOI Listing

Publication Analysis

Top Keywords

acute lymphocytic
4
lymphocytic leukemia
4
leukemia adults
4
adults pathologic
4
pathologic features
4
features prognosis
4
prognosis acute
4
acute lymphoblastic
4
lymphoblastic leukemia
4
leukemia malignant
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!